Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Club
$299/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Microbix Biosystems Inc. (T:MBX)

Business Focus: Biotechnology & Medical Research

Mar 31, 2021 07:00 am ET
Microbix Announces Annual and Special Meeting Voting Results
Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF)( “Microbix®” or the Company”), a life sciences innovator and exporter, announces the voting results from the Annual and Special Meeting of Shareholders of the Company (the “Meeting”) which was held...
Mar 15, 2021 07:00 am ET
Microbix & Seegene Canada Form COVID-Variant Collaboration
Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF, Microbix®), a life sciences innovator and exporter, and Seegene Canada Inc. (Seegene®), a provider of leading-edge molecular diagnostics assays and instruments (made by Seegene Inc. of Seoul,...
Mar 11, 2021 07:00 am ET
Microbix Antigen-test QAPs Now Available For Clinical Use
Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF, Microbix®), a life sciences innovator and exporter, announces the availability of more of its Quality Assessment Products (QAPs™) as In-Vitro Diagnostic “IVD” Controls – to monitor the workflow...
Feb 18, 2021 07:00 am ET
Microbix Announces Issuance of Stock Options Using Shareholder-Approved Plan to Incentivize and Retain
Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF, Microbix®), a life sciences innovator and exporter, announces the issuance of stock options under its shareholder-approved 2018 stock option plan (the “Stock Option Plan”), as part of its...
Feb 16, 2021 07:00 am ET
Microbix Announces Quality Products Distribution Agreement
Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF, Microbix®), a life sciences innovator and exporter, announces an agreement (Agreement) with Oneworld Accuracy Inc. (1WA) to distribute Microbix’s Quality Assessment Products (QAPs™) on a...
Feb 11, 2021 08:22 am ET
Microbix Reports Results for Q1 Fiscal 2021
Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF, Microbix®), a life sciences innovator and exporter, reports results for the first quarter of its fiscal 2021, the three-months ended December 31, 2020 (“Q1”), with record sales and continued...
Feb 09, 2021 07:00 am ET
Microbix Announces Material First Sales of Viral Transport Medium
Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF, Microbix®), a life sciences innovator and exporter, is pleased to announce material first sales of its viral transport medium (generically known as VTM and branded as DxTM™) that supports Canadian...
Jan 28, 2021 07:00 am ET
Microbix Viral Transport Medium Now Available
Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF, Microbix®), a life sciences innovator and exporter, is pleased to announce the commercial availability of its viral transport medium (VTM) to support Canadian RT-PCR (molecular) testing for the...
Dec 21, 2020 07:00 am ET
Microbix & Copan Italia Execute Strategic Agreement
Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF, Microbix®), a life sciences innovator and exporter, and Copan Italia S.p.A. (Copan®), the global leader in specimen collection technologies, announce their execution of a strategic agreement...
Dec 18, 2020 07:38 am ET
Microbix Reports Results for Fiscal 2020
Microbix Biosystems Inc. (TSX: MBX, Microbix®), a life sciences innovator making critical ingredients that enable the production of clinical diagnostics and creating medical devices that help ensure test accuracy, reports results for its 2020...
Dec 15, 2020 07:00 am ET
Microbix Presenting Product Results at AACC
Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF, Microbix®), a life sciences innovator and exporter, announces it has been invited to present about the performance of two types of its test-workflow Quality Assessment Products (QAPs™) at the 2020...
Dec 07, 2020 07:00 am ET
Microbix Announces Addition to Board of Directors
Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF, Microbix®), a life sciences innovator and exporter, announces that Mr. Anthony J. Giovinazzo, an accomplished leader in the international life sciences industry, has joined its Board of Directors....
Oct 29, 2020 07:00 am ET
Microbix Discloses New Products, Sales and Capacity
Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF, Microbix®), a life sciences innovator and exporter, announces the availability and initial material sales of “onboarding” kits of its quality assessment products (QAPs™), designed to help testing...
Oct 20, 2020 07:00 am ET
Microbix Creates Further COVID-19 Quality Assessment Products
Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF, Microbix®), a life sciences innovator and exporter, announces its creation, external verification, initial sales, and first shipments of a new class of quality assessment products (QAPs™) to help...
Oct 15, 2020 07:00 am ET
Microbix Launches New STI-Related Quality Assessment Products
Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF, Microbix®), a life sciences innovator and exporter, announces its creation, external verification, and registration of new quality assessment products (QAPs™) to help ensure the accuracy of...
Oct 13, 2020 07:00 am ET
Ontario Helps Microbix Ensure Provincial COVID Testing Capacity
Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF, Microbix®), a life sciences innovator and exporter, is pleased to announce the execution of a grant agreement with the Ontario Together Fund (OTF) of the Ministry of Economic Development, Job...
Sep 22, 2020 07:00 am ET
Microbix Presenting COVID-19 Product Results to Industry
Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF, Microbix®), an award-winning life sciences innovator and exporter, announces it is has been invited to present about the performance of its COVID-19 in-vitro diagnostics (IVD) quality assessment...
Sep 17, 2020 07:00 am ET
Microbix Announces Extension of Warrant Expiry Dates
Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF, Microbix®), an award-winning life sciences innovator and exporter, announces it has applied to the TSX to extend the term of an aggregate of 7,413,052 common share purchase warrants (“Warrants”)...
Sep 15, 2020 07:00 am ET
Microbix Announces Board Changes
Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF, Microbix®), an award-winning life sciences innovator and exporter, announces that its founder and Executive Chairman William J. (Bill) Gastle has elected to retire effective October 15, 2020, and...
Sep 10, 2020 07:00 am ET
Microbix’s REDx™ Controls Attain Australian TGA Registration
Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF, Microbix®), an award-winning life sciences innovator and exporter, is pleased to announce attainment of Australian Therapeutic Goods Administration (TGA) registration for its COVID-19 and high-risk...
Aug 14, 2020 07:00 am ET
Microbix Reports Results for Q3 Fiscal 2020
Microbix Biosystems Inc. (TSX: MBX, Microbix®), an award-winning life sciences innovator and exporter, reports results for its third quarter and year to date fiscal 2020 (Q3 and YTD) ended June 30, 2020, with an increase of 141% in sales of...
Jul 14, 2020 07:00 am ET
Microbix Shares Become Available for U.S. Investors
Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF, Microbix®), an award-winning life sciences innovator and exporter, announces that it has completed two processes to make its common shares available for U.S. investors to buy and sell; (i) the...
Jun 05, 2020 07:00 am ET
Microbix COVID-19 QAPs Attain EU “CE mark” Registration
Microbix Biosystems Inc. (TSX: MBX, Microbix®), an award-winning life sciences innovator and exporter, is pleased to announce the attainment of European Union “CE mark” (Conformité Européene) registration for its SARS-CoV-2 quality assessment...
Jun 04, 2020 07:00 am ET
Microbix Announces Quality Products Distribution Agreement
Microbix Biosystems Inc. (TSX: MBX, Microbix®), an award-winning life sciences innovator and exporter, announces the appointment of Alpha-Tec Systems, Inc. (Alpha-Tec), a Calibre Scientific Inc. firm, as distributor of its Quality Assessment...
Jun 01, 2020 09:55 am ET
Microbix Engaged to Develop & Supply Custom QAPs
Microbix Biosystems Inc. (TSX: MBX, Microbix®), an award-winning life sciences innovator and exporter, announces that it has been engaged to develop and supply custom quality assessment products (QAPs™) to support the registration and sales of a...
May 27, 2020 07:00 am ET
Microbix Expanding QAPs™ Production Capacity
Microbix Biosystems Inc. (TSX: MBX, Microbix®), an award-winning life sciences innovator and exporter, announces that it has begun a build-out of its second facility that is initially intended to support a tenfold increase of production capacity...
May 19, 2020 07:00 am ET
Microbix Achieves Full Utilization of its Bioreactors
Microbix Biosystems Inc. (TSX: MBX, Microbix®), an award-winning life sciences innovator and exporter, announces that it has achieved full utilization of the six bioreactor units it installed for manufacturing the “antigens” which are at the core...
May 15, 2020 07:38 am ET
Microbix Announces Quality Products Distribution Agreement
Microbix Biosystems Inc. (TSX: MBX, Microbix®), an award-winning life sciences innovator and exporter, announces the appointment of R-Biopharm AG (R-Biopharm) as distributor of its Quality Assessment Products (QAPs™) in eleven (11) countries....
May 14, 2020 07:00 am ET
Microbix Reports Results for Q2 Fiscal 2020
Microbix Biosystems Inc. (TSX: MBX, Microbix®), an award-winning life sciences innovator and exporter, reports results for its second quarter and first half of fiscal 2020 (“Q2” and “H1”) ended March 31, 2020, with the timing of product shipments...
May 12, 2020 07:00 am ET
Microbix Announces Quality Products Distribution Agreement
Microbix Biosystems Inc. (TSX: MBX, Microbix®), an award-winning life sciences innovator and exporter, announces the appointment of Diagnostic International Distribution S.p.A. of Milan (D.I.D.) as distributor of its Quality Assessment Products...
May 07, 2020 07:00 am ET
Microbix COVID-19 QAPs Now Available for U.S. Labs
Microbix Biosystems Inc. (TSX: MBX, Microbix®), an award-winning life sciences innovator and exporter, is pleased to announce U.S. availability of its SARS-CoV-2 quality assessment products (QAPs™) –  FDA registration enabling immediate usage by...
May 06, 2020 07:00 am ET
Microbix Begins Providing COVID-19 Test Quality Products
Microbix Biosystems Inc. (TSX: MBX, Microbix®), an award-winning life sciences innovator and exporter, announces that it has begun providing its REDx™FLOQ® SARS-CoV-2 swab-format and REDx™ SARS-CoV-2 vial format quality assessment products (QAPs™)...
Apr 27, 2020 07:00 am ET
Microbix Announces Quality Products Distribution Agreement
Microbix Biosystems Inc. (TSX: MBX, Microbix®), an award-winning life sciences innovator and exporter, announces the appointment of Labquality Oy (Labquality) as a distributor of its Quality Assessment Products (QAPs™) in seven (7) countries....
Apr 21, 2020 12:00 pm ET
IIROC Trade Resumption - MBX
TORONTO, April 21, 2020 /CNW/ - Trading resumes in:
Apr 21, 2020 11:49 am ET
Microbix Attains Health Canada Establishment Licensing
Microbix Biosystems Inc. (TSX: MBX, Microbix®), a life sciences innovator and exporter, announces that it has attained medical devices establishment licensing from Health Canada, enabling the immediate usage of its quality assessment products...
Apr 21, 2020 10:35 am ET
IIROC Trading Halt - MBX
TORONTO, April 21, 2020 /CNW/ - The following issues have been halted by IIROC:
Apr 21, 2020 07:00 am ET
Microbix Participating in COVID-19 Virtual Conference
Microbix Biosystems Inc. (TSX: MBX, Microbix®), an award-winning life sciences innovator and exporter, announces that it will be participating in the “Virtual COVID & Healthcare Mini Conference” being hosted by Adelaide Capital on April 23 from...
Apr 09, 2020 07:00 am ET
Microbix & Oneworld Create COVID-19 Test Quality Program
Microbix Biosystems Inc. (TSX: MBX, Microbix®) and Oneworld Accuracy (1WA) announce a strategic collaboration to provide a global external quality assessment (EQA) program to support clinically-effective COVID-19 testing. Based in Canada, this...
Apr 01, 2020 05:36 pm ET
Microbix Announces Annual and Special Meeting Voting Results
Microbix Biosystems Inc. (TSX: MBX, “Microbix®” or the “Company”), a life sciences innovator making critical ingredients that enable the production of clinical diagnostics and creating medical devices that help ensure test accuracy, announces the...
Mar 30, 2020 07:00 am ET
Microbix Creates Quality Assessment Product for COVID-19 Tests
Microbix Biosystems Inc. (TSX: MBX, Microbix®) announces the creation, verification, and imminent commercial availability of a quality assessment product (QAP™) to help ensure the accuracy of COVID-19 disease testing. By creating this unique...
Mar 25, 2020 07:00 am ET
Microbix Annual General Meeting Process Update
Microbix Biosystems Inc. (TSX: MBX, Microbix®), a life sciences innovator making critical ingredients that enable the production of clinical diagnostics and creating medical devices that help ensure test accuracy, provides an update about its...
Mar 24, 2020 07:00 am ET
Microbix Announces Quality Products Distribution Agreement
Microbix Biosystems Inc. (TSX: MBX, Microbix®),  a life sciences innovator making critical ingredients that enable the production of clinical diagnostics and creating medical devices that help ensure test accuracy, announces the appointment of The...
Feb 25, 2020 07:00 am ET
Microbix Announces Issuance of Stock Options
Microbix Biosystems Inc. (TSX: MBX, Microbix®), a life sciences innovator making critical ingredients that enable the production of clinical diagnostics and creating medical devices that help ensure test accuracy, announces the issuance of stock...
Feb 13, 2020 07:00 am ET
Microbix Reports Results for Q1 Fiscal 2020
Microbix Biosystems Inc. (TSX: MBX, Microbix®), a life sciences innovator making critical ingredients that enable the production of clinical diagnostics and creating medical devices that help ensure test accuracy, reports results for its first...
Jan 31, 2020 07:00 am ET
Microbix Completes Non-Brokered Private Placement of $2.3 million
Microbix Biosystems Inc. (TSX: MBX, Microbix®), a life sciences innovator making critical ingredients that enable the production of clinical diagnostics and creating medical devices that help ensure test accuracy, announces that it has completed a...
Dec 20, 2019 08:21 am ET
Microbix Reports Results for Fiscal 2019
Microbix Biosystems Inc. (TSX: MBX, Microbix®), a life sciences innovator making critical ingredients that enable the production of clinical diagnostics and creating medical devices that help ensure test accuracy, reports results for its fiscal...
Dec 02, 2019 07:00 am ET
Microbix Invited to Present Product Results at HPV Congress
Microbix Biosystems Inc. (TSX: MBX, Microbix®), a life sciences innovator making critical ingredients that enable the production of clinical diagnostics and creating medical devices that help ensure test accuracy, announces it has been invited to...
Nov 18, 2019 07:00 am ET
Microbix Wins Ontario Business Award
Microbix Biosystems Inc. (TSX: MBX, Microbix®), a life sciences innovator making critical ingredients that enable the production of clinical diagnostics and creating medical devices (QAPs™) that help ensure test accuracy, announces it has been...
Oct 08, 2019 07:00 am ET
Microbix Presenting Product Results at Industry Conference
Microbix Biosystems Inc. (TSX: MBX, Microbix®), an innovator of clinical diagnostic materials and quality control medical devices, announces it is making two presentations about the performance of its in-vitro diagnostics quality products (IVD...
Oct 01, 2019 07:00 am ET
Microbix Presenting at StableView TECH19 Conference
Microbix Biosystems Inc. (TSX: MBX, Microbix®), an innovator of clinical diagnostic materials and quality control medical devices, announces that it will be presenting to investors about Microbix at the StableView TECH19 conference, organized by...
Sep 25, 2019 07:00 am ET
Microbix Presenting at Muskoka Capital Conference
Microbix Biosystems Inc. (TSX: MBX, Microbix®), an innovator of clinical diagnostic materials and medical devices for test quality control, announces that it will be presenting to investors about Microbix at the Muskoka Capital Conference,...
Sep 19, 2019 07:00 am ET
Microbix Quality Products Enter U.S. Market
Microbix Biosystems Inc. (TSX: MBX, Microbix®), an innovator of biological products and technologies, is pleased to announce U.S. availability of four innovative in-vitro diagnostic (IVD) control products for evaluating performance, procedures, and...
Sep 05, 2019 07:00 am ET
Microbix Quality Products Attain European Registration
Microbix Biosystems Inc. (TSX: MBX, Microbix®), an innovator of biological products and technologies, is pleased to announce European registration for four innovative in-vitro diagnostic (IVD) control products for evaluating performance,...
Aug 12, 2019 07:00 am ET
Microbix Reports Results for Q3 Fiscal 2019
Microbix Biosystems Inc. (TSX: MBX, Microbix®), an innovator of biological products and technologies, reports results for its third quarter and nine months of fiscal 2019, the three-month and nine-month periods ending June 30, 2019 (“Q3” & “YTD”),...
Aug 01, 2019 07:00 am ET
Microbix Provides Bioreactor Update
Microbix Biosystems Inc. (TSX: MBX, Microbix®), an innovator of biological products and technologies, provides an update on the conversion of its highest-selling product into bioreactors – that the largest customer for that antigen has confirmed...
Jul 30, 2019 07:00 am ET
FedDev Ontario Supports New Microbix Facility in Mississauga
Microbix Biosystems Inc. (TSX: MBX, Microbix®), an innovator of biological products and technologies, is pleased to announce the execution of a contribution agreement with the Federal Economic Development Agency for Southern Ontario (FedDev...
May 13, 2019 07:00 am ET
Microbix Reports Results for Q2 Fiscal 2019
Microbix Biosystems Inc. (TSX: MBX, Microbix®), an innovator of biological products and technologies, reports results for its second quarter and first half of fiscal 2019, the three-month and six-month periods ending March 31, 2019 (“Q2” & “H1”),...
Apr 29, 2019 07:00 am ET
Microbix to Present at Bloom Burton Conference
Microbix Biosystems Inc. (TSX: MBX, Microbix®), an innovator of biological products and technologies, announces that its CEO, Cameron Groome, has been invited to present at the 2019 Bloom Burton & Co. Healthcare Investment Conference, being held at...
Apr 18, 2019 07:00 am ET
Microbix Announces Management Changes
Microbix Biosystems Inc. (TSX: MBX, Microbix®), an innovator of biological products and technologies, announces that it has appointed Dr. Kenneth (Ken) Hughes as its Chief Operating Officer (“COO”) and that Mrs. Kathryn Froh, its Vice President,...
Mar 28, 2019 04:21 pm ET
Microbix Announces Annual Meeting Voting Results
Microbix Biosystems Inc. (TSX: MBX, “Microbix” or the “Company”), an innovator of biological products and technologies, announces the voting results from the Annual Meeting of Shareholders (the “Meeting”) which was held on March 27, 2019. At the...
Feb 25, 2019 07:00 am ET
Microbix Announces Issuance of Stock Options
Microbix Biosystems Inc. (TSX: MBX, Microbix®), an innovator of biological products and technologies, announces the issuance of stock options under its shareholder-approved 2018 stock option plan (the “Stock Option Plan”), as part of its...
Feb 12, 2019 07:00 am ET
Microbix Reports Results for Q1 Fiscal 2019
Microbix Biosystems Inc. (TSX: MBX, Microbix®), an innovator of biological products and technologies, reports results for its first quarter of fiscal 2019, the three-month period ending December 31, 2018 (“Q1”), with lower sales, improving...
Feb 05, 2019 07:00 am ET
Microbix Provides Quality Assessment Products Update
Microbix Biosystems Inc. (TSX: MBX, Microbix®), an innovator of biological products and technologies, provides an update on the expansion of its quality assessment product lines, announcing the addition of new customers, more products, and steps to...
Dec 24, 2018 07:00 am ET
Microbix Enhances Quality Management System
Microbix Biosystems Inc. (TSX: MBX, Microbix®), an innovator of biological products and technologies, announces that it has attained the ISO 13485:2016 Medical Devices certification – an enhancement to its quality management system that is expected...
Dec 21, 2018 08:30 am ET
Microbix Reports Results for Fiscal 2018
Microbix Biosystems Inc. (TSX: MBX, Microbix®), an innovator of biological products and technologies, reports results for its fourth quarter of fiscal 2018, the three-month period ending September 30, 2018 (“Q4”), with strong sales and progress...
Nov 19, 2018 07:00 am ET
Microbix Wins Business Award of Excellence
Microbix Biosystems Inc. (TSX: MBX, Microbix®), an innovator of biological products and technologies, announces that it has been recognized with the 2018 Business Innovation Award by the Mississauga Board of Trade (MBOT). The award was provided to...
Nov 06, 2018 07:00 am ET
Microbix Exhibiting at MEDICA Trade Fair
Microbix Biosystems Inc. (TSX: MBX, Microbix®), an innovator of biological products and technologies, announces that it will be exhibiting its antigens and quality assessment products at MEDICA, a leading international trade fair for the medical...
Sep 27, 2018 07:00 am ET
Microbix to Present at Muskoka Capital Conference
Microbix Biosystems Inc. (TSX: MBX, Microbix®), an innovator of biological products and technologies, announces that it will be presenting to investors about Microbix at the Muskoka Capital Conference, organized by Capital Event Conferences and...
Aug 14, 2018 07:00 am ET
Microbix Reports Record Third Quarter Sales
Microbix Biosystems Inc. (TSX: MBX, Microbix®), an innovator of biological products and technologies, reports financial results for its third quarter of fiscal 2018, the three-month period ending June 30, 2018 (“Q3”), with record sales and progress...
Jul 26, 2018 07:00 am ET
Microbix Exhibiting at AACC Exposition
Microbix Biosystems Inc. (TSX:MBX) (Microbix®), an innovator of biological products and technologies, announces that it will be exhibiting its Quality Assessment Products (QAPs™) at the 70th annual clinical laboratory exposition of the American...
Jul 12, 2018 07:00 am ET
Microbix to Present at Okanagan Capital Conference
Microbix Biosystems Inc. (TSX:MBX) (Microbix®), an innovator of biological products and technologies, announces that it will be presenting to investors about Microbix at the Okanagan Capital Conference, organized by Capital Event Conferences and...
May 14, 2018 07:00 am ET
Microbix Reports Record Second Quarter Sales
Microbix Biosystems Inc. (TSX:MBX) (Microbix®), an innovator of biological products and technologies, reports financial results for its second quarter of fiscal 2018, the three-month period ending March 31, 2018 (“Q2”), with record sales and...
May 08, 2018 07:00 am ET
Microbix Completes Multiple Facility Upgrades
Microbix Biosystems Inc. (TSX:MBX) (Microbix®), an innovator of biological products and technologies, announces the completion of multiple upgrades to its production facility, to improve its revenue capacity and in support of corporate growth...
Apr 30, 2018 07:00 am ET
Microbix to Present at Bloom Burton Conference
Healthcare Investment Conference in Toronto on May 2 & 3, 2018
Apr 26, 2018 07:00 am ET
Microbix Engages Drug Licensing Advisor
Torreya Partners to Assist with Kinlytic® urokinase
Apr 02, 2018 05:00 pm ET
Microbix Announces Annual and Special Meeting Voting Results
TORONTO, April 02, 2018 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX:MBX) (Microbix®), an innovator of biological products and technologies, announces the voting results from the Annual and Special Meeting of Shareholders (the “Meeting”) that was held on March...
Mar 19, 2018 02:30 pm ET
Soricimed Announces the Appointment of Dr. Marc Rubin and Mr. Vaughn Embro-Pantalony to Board of Directors
MONCTON, New Brunswick, March 19, 2018 (GLOBE NEWSWIRE) -- Soricimed Biopharma Inc. ("Soricimed"), a clinical-stage pharmaceutical company discovering and developing targeted cancer therapeutics, is pleased to announce that Marc Rubin, MD and Vaughn Embro-Pantalony have been appointed to...
Feb 14, 2018 07:00 am ET
Microbix Reports Record First Quarter Sales
Year-Over-Year Sales Growth of 48%
Jan 29, 2018 07:00 am ET
Microbix Featured at Cantech Investment Conference
Invited onto Panel about Managing Canadian Healthcare Companies for Growth
Jan 18, 2018 07:00 am ET
Microbix Expands Quality Assessment Product Family
Microbix Biosystems Inc. (TSX: MBX) (Microbix(R)), an innovator of biological products and technologies, announces the expansion of its quality assessment product family, with 48 new products being completed and made available for sale under its PTDx(TM) and PROCEEDx(TM) brands.
Jan 18, 2018 06:58 am ET
Microbix Expands Quality Assessment Product Family
Microbix Biosystems Inc. (TSX:MBX) (Microbix®), an innovator of biological products and technologies, announces the expansion of its quality assessment product family, with 48 new products being completed and made available for sale under its...
Dec 21, 2017 07:00 am ET
Microbix Reports Full Year and Fourth Quarter Results
Microbix Biosystems Inc. (TSX: MBX), an innovator of biological products and technologies, reports financial results for its fiscal year and fourth quarter ended 30 September, 2017 ("2017" and "Q4").
Dec 21, 2017 06:58 am ET
Microbix Reports Full Year and Fourth Quarter Results
Microbix Biosystems Inc. (TSX:MBX), an innovator of biological products and technologies, reports financial results for its fiscal year and fourth quarter ended 30 September, 2017 ("2017" and "Q4"). Management Discussion In 2017,...
Nov 27, 2017 07:00 am ET
Microbix Confirms Ramp-up of Production
Microbix Biosystems Inc. (TSX: MBX), a developer and marketer of biological products and technologies, confirms its production ramp-up, with a 500% increase in bioreactor capacity and other processing upgrades.
Nov 27, 2017 06:58 am ET
Microbix Confirms Ramp-up of Production
Microbix Biosystems Inc. (TSX:MBX), a developer and marketer of biological products and technologies, confirms its production ramp-up, with a 500% increase in bioreactor capacity and other processing upgrades. Microbix' revenues are mainly...
Oct 27, 2017 07:00 am ET
Microbix Completes Second Tranche of Brokered Private Placement
Microbix Biosystems Inc. (TSX: MBX) ("Microbix" or the "Company"), a developer and marketer of biological products and technologies, announces that it has completed a second and final tranche of the brokered private placement financing announced on October 19, 2017. An aggregate of 7,784,500 Units were issued in the first tranche for gross proceeds of $2.33 million. Microbix has now closed a second tranche of private placement financing for further gross proceeds of $1.17 million, resulting in the issue of 3,882,133 more Units at a price of $0.30 per Unit.
Oct 27, 2017 06:58 am ET
Microbix Completes Second Tranche of Brokered Private Placement
Microbix Biosystems Inc. (TSX:MBX) ("Microbix" or the "Company"), a developer and marketer of biological products and technologies, announces that it has completed a second and final tranche of the brokered private placement financing announced on...
Oct 19, 2017 07:00 am ET
Microbix Completes Brokered Private Placement
Microbix Biosystems Inc. (TSX: MBX) ("Microbix" or the "Company"), a developer and marketer of biological products and technologies, announces that it has completed a brokered private placement financing totaling $2.33 million dollars, resulting in the issue of 7,784,500 million units ("Units") at a price of $0.30 per unit.
Oct 19, 2017 06:58 am ET
Microbix Completes Brokered Private Placement
Microbix Biosystems Inc. (TSX:MBX) ("Microbix" or the "Company"), a developer and marketer of biological products and technologies, announces that it has completed a brokered private placement financing totaling $2.33 million dollars, resulting in...
Oct 11, 2017 07:00 am ET
Microbix Announces End of Legal Dispute
Microbix Biosystems Inc. (TSX: MBX), an innovator of biological products and technologies, is pleased to announce the withdrawal of legal claims alleging patent infringement that were filed in Canadian Federal Court against Microbix by ZeptoMetrix Corporation in October, 2016.
Sep 13, 2017 08:30 am ET
Microbix Announces First Shipment of Bioreactor Antigen
Microbix Biosystems Inc. (TSX: MBX), a developer and marketer of biological products and technologies, announces its first full-scale shipment of antigen produced using its new bioreactor manufacturing process, following customer validation.
Sep 13, 2017 08:28 am ET
Microbix Announces First Shipment of Bioreactor Antigen
Microbix Biosystems Inc. (TSX:MBX), a developer and marketer of biological products and technologies, announces its first full-scale shipment of antigen produced using its new bioreactor manufacturing process, following customer validation....
Aug 24, 2017 08:30 am ET
Microbix to Amend Share Purchase Warrant Terms
Microbix Biosystems Inc. (TSX: MBX), a developer and marketer of biological products and technologies, announces it has applied to the TSX to amend the terms of 1,500,000 common share purchase warrants (the "Warrants") issued in connection with a non-brokered private placement and held by one of its independent directors.
Aug 24, 2017 08:28 am ET
Microbix to Amend Share Purchase Warrant Terms
 Microbix Biosystems Inc. (TSX:MBX), a developer and marketer of biological products and technologies, announces it has applied to the TSX to amend the terms of 1,500,000 common share purchase warrants (the "Warrants") issued in connection with...
Aug 14, 2017 07:00 am ET
Microbix Reports Record Third Quarter & Nine Month Sales
Microbix Biosystems Inc. (TSX: MBX), an innovator of biological products and technologies, today reports financial results for its fiscal third quarter and nine months ended June 30, 2017 ("Q3" and "9 Mo.").
Aug 14, 2017 06:58 am ET
Microbix Reports Record Third Quarter & Nine Month Sales
Microbix Biosystems Inc. (TSX:MBX), an innovator of biological products and technologies, today reports financial results for its fiscal third quarter and nine months ended June 30, 2017 ("Q3" and "9 Mo."). Third Quarter Financial Results...
Aug 08, 2017 08:00 am ET
Microbix Announces Expanded Customer Supply Agreement
Microbix Biosystems Inc. (TSX: MBX), an innovator of biological products and technologies, announces the execution of an agreement to supply an existing long-term customer with an increasing quantity of Microbix' viral antigen products over the next five years, with the parties having the option to extend that term. Sales from the agreement are expected to total $25 million, with approximately $10 million being new business.
Aug 08, 2017 07:58 am ET
Microbix Announces Expanded Customer Supply Agreement
Microbix Biosystems Inc. (TSX:MBX), an innovator of biological products and technologies, announces the execution of an agreement to supply an existing long-term customer with an increasing quantity of Microbix' viral antigen products over the next...
Jul 24, 2017 08:59 am ET
Microbix Announces Leadership Transition
Microbix Biosystems Inc. (TSX:MBX) ("Microbix" or the "Company") a developer and marketer of biological products and technologies, announces that it has appointed Mr. Cameron Groome as its President and CEO, with Mr. Vaughn Embro-Pantalony retiring...
Jul 24, 2017 08:59 am ET
Microbix Announces Leadership Transition
Microbix Biosystems Inc. (TSX: MBX) ("Microbix" or the "Company") a developer and marketer of biological products and technologies, announces that it has appointed Mr. Cameron Groome as its President and CEO, with Mr. Vaughn Embro-Pantalony retiring from those positions but remaining an executive director working closely with Mr. Groome to ensure a smooth leadership transition.
May 15, 2017 08:30 am ET
Microbix Reports Strong First Half Sales Growth
Microbix Biosystems Inc. (TSX: MBX) ("Microbix" or the "Company"), an innovator of biological products and technologies, today reported financial results for its fiscal second quarter and six months ended March 31, 2017 ("Q2" and "H1").
May 15, 2017 08:28 am ET
Microbix Reports Strong First Half Sales Growth
Microbix Biosystems Inc. (TSX:MBX) ("Microbix" or the "Company"), an innovator of biological products and technologies, today reported financial results for its fiscal second quarter and six months ended March 31, 2017 ("Q2" and "H1")....
May 01, 2017 08:00 am ET
Microbix Consults with FDA Regarding Plans for Kinlytic(R) Urokinase
Microbix Biosystems Inc. (TSX: MBX) ("Microbix" or the "Company") a developer and marketer of biological products and technologies, announces that it has consulted with the U.S. Food and Drug Administration (the "FDA") regarding the Company's plans to return its thrombolytic biologic drug, Kinlytic(R) Urokinase ("Kinlytic"), to the U.S. market.
May 01, 2017 07:58 am ET
Microbix Consults with FDA Regarding Plans for Kinlytic(R) Urokinase
Microbix Biosystems Inc. (TSX:MBX) ("Microbix" or the "Company") a developer and marketer of biological products and technologies, announces that it has consulted with the U.S. Food and Drug Administration (the "FDA") regarding the Company's plans...
Apr 28, 2017 07:58 am ET
Microbix Announces Amendments to Debenture and Share Purchase Warrants
Not for distribution in the United States or through United States wire services. Microbix Biosystems Inc. (TSX:MBX), an innovator of biological products and technologies, announced today it has negotiated an extension...
Mar 30, 2017 08:51 am ET
Microbix Announces Annual Meeting Voting Results
Microbix Biosystems Inc. (TSX:MBX) ("Microbix" or the "Company"), an innovator of biological products and technologies, announces the results of the Annual Meeting of Shareholders which was held on March 29, 2017, at which 37.07% of the issued and...
Mar 30, 2017 08:51 am ET
Microbix Announces Annual Meeting Voting Results
Microbix Biosystems Inc. (TSX: MBX) ("Microbix" or the "Company"), an innovator of biological products and technologies, announces the results of the Annual Meeting of Shareholders which was held on March 29, 2017, at which 37.07% of the issued and outstanding shares were represented. Shareholders voted in favour of all resolutions brought before the meeting. A detailed description of all resolutions that were voted on can be reviewed in the Company's Information Circular which was filed on SEDAR on February 22, 2017. All of the director nominees listed in the Information
Feb 14, 2017 09:44 am ET
Microbix Reports Significant Revenue Growth in First Quarter
Microbix Biosystems Inc. (TSX: MBX) ("Microbix" or the "Company"), an innovator of biological products and technologies, today reported financial results for its fiscal first quarter ended December 31, 2016.
Feb 14, 2017 09:44 am ET
Microbix Reports Significant Revenue Growth in First Quarter
Microbix Biosystems Inc. (TSX:MBX) ("Microbix" or the "Company"), an innovator of biological products and technologies, today reported financial results for its fiscal first quarter ended December 31, 2016. First Quarter Financial Results...
Jan 12, 2017 08:00 am ET
Microbix Appoints Meridian Life Science as Distributor in Asia Pacific
Microbix Biosystems Inc. (TSX: MBX) ("Microbix"), an innovator of biological products and technologies, today announced it has signed a distribution agreement (the "Agreement") with Meridian Life Science, Inc. ("Meridian") a wholly owned company of Meridian Bioscience, Inc. (NASDAQ: VIVO) a fully integrated global diagnostic and life science company.
Jan 12, 2017 07:58 am ET
Microbix Appoints Meridian Life Science as Distributor in Asia Pacific
Microbix Biosystems Inc. (TSX:MBX) ("Microbix"), an innovator of biological products and technologies, today announced it has signed a distribution agreement (the "Agreement") with Meridian Life Science, Inc. ("Meridian") a wholly owned company of...
Dec 23, 2016 08:00 am ET
Microbix Reports Fiscal 2016 Results Continued Profitability and Strong Revenue Growth
Microbix Biosystems Inc. (TSX: MBX) ("Microbix" or the "Company"), an innovator of biological products and technologies, today reported financial results for the three months and year ended September 30, 2016, and provided an update on its operations.
Dec 23, 2016 07:58 am ET
Microbix Reports Fiscal 2016 Results Continued Profitability and Strong Revenue Growth
Microbix Biosystems Inc. (TSX:MBX) ("Microbix" or the "Company"), an innovator of biological products and technologies, today reported financial results for the three months and year ended September 30, 2016, and provided an update on its...
Dec 12, 2016 08:42 am ET
Microbix Arranges New Revolving Credit Facility
Microbix Biosystems Inc. (TSX: MBX) ("Microbix" or the "Company"), an innovator of biological products and technologies, today announced that it has arranged a new secured revolving credit facility jointly with The Toronto-Dominion Bank ("TD Bank") and Export Development Canada ("EDC").
Dec 12, 2016 08:42 am ET
Microbix Arranges New Revolving Credit Facility
Microbix Biosystems Inc. (TSX:MBX) ("Microbix" or the "Company"), an innovator of biological products and technologies, today announced that it has arranged a new secured revolving credit facility jointly with The Toronto-Dominion Bank ("TD Bank")...
Nov 01, 2016 08:30 am ET
Microbix Appoints New Chief Financial Officer
Microbix Biosystems Inc. (TSX: MBX), an innovator of biological products and technologies, today announced that Charles Wallace, the Company's Chief Financial Officer, is retiring on December 31, 2016 after serving in this capacity since September 2013. Microbix also announced that Jim Currie is joining the Company on November 1, 2016 as the newly appointed Chief Financial Officer.
Nov 01, 2016 08:28 am ET
Microbix Appoints New Chief Financial Officer
Microbix Biosystems Inc. (TSX:MBX), an innovator of biological products and technologies, today announced that Charles Wallace, the Company's Chief Financial Officer, is retiring on December 31, 2016 after serving in this capacity since September...
Oct 19, 2016 08:30 am ET
Microbix Announces Preliminary Sales for 2016
Microbix Biosystems Inc. (TSX: MBX), an innovator of biological products and technologies, today announced preliminary revenue results (unaudited) for its fourth quarter and full year ending September 30, 2016. The preliminary results are subject to the Company's annual audit including a review of its revenue recognition policies under IFRS. The Company's audited financial results will be available towards the end of December 2016.
Oct 19, 2016 08:28 am ET
Microbix Announces Preliminary Sales for 2016
Microbix Biosystems Inc. (TSX:MBX), an innovator of biological products and technologies, today announced preliminary revenue results (unaudited) for its fourth quarter and full year ending September 30, 2016. The preliminary results are subject to...
Oct 11, 2016 01:42 pm ET
Zeptometrix Files Infringement Action Against Microbix
Microbix Biosystems Inc. (TSX:MBX), an innovator of biological products and technologies, today announced that Zeptometrix Corporation has filed a statement of claim against Microbix in Canadian Federal Court alleging infringement of its Canadian...
Oct 11, 2016 01:42 pm ET
Zeptometrix Files Infringement Action Against Microbix
Microbix Biosystems Inc. (TSX: MBX), an innovator of biological products and technologies, today announced that Zeptometrix Corporation has filed a statement of claim against Microbix in Canadian Federal Court alleging infringement of its Canadian patent.
Aug 15, 2016 07:45 am ET
Microbix Revenue Continues to Grow in Third Quarter
Microbix Biosystems Inc. (TSX: MBX), an innovator of biological products and technologies, today reported financial results for its third quarter ending June 30, 2016.
Aug 15, 2016 07:43 am ET
Microbix Revenue Continues to Grow in Third Quarter
Microbix Biosystems Inc. (TSX:MBX), an innovator of biological products and technologies, today reported financial results for its third quarter ending June 30, 2016. Third Quarter Financial Results Total revenue was $2,253,373...
May 16, 2016 07:00 am ET
Microbix Revenue Grows 7% in Second Quarter
Microbix Biosystems Inc. (TSX: MBX), an innovator of biological products and technologies, today reported financial results for its second quarter ending March 31, 2016.
May 16, 2016 06:58 am ET
Microbix Revenue Grows 7% in Second Quarter
Microbix Biosystems Inc. (TSX:MBX), an innovator of biological products and technologies, today reported financial results for its second quarter ending March 31, 2016. Second Quarter Financial Results Total revenue was $2,729,779...
Apr 07, 2016 02:59 pm ET
Microbix Announces Annual and Special Meeting Voting Results
Microbix Biosystems Inc. (TSX: MBX) ("Microbix" or the "Company"), an innovator of biological products and technologies, announces the results of the Annual and Special Meeting of Shareholders that was held on April 6, 2016, at which 45.98% of the issued and outstanding shares were represented. Shareholders voted in favour of all resolutions brought before the meeting. A detailed description of all resolutions that were voted on can be reviewed in the Company's Information Circular, which was filed on SEDAR on March 7, 2016. All of the director nominees listed in the